H H Balfour

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

M A Fischl, M D Hughes, S. Hammer, 1997, The New England journal of medicine.

Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection

S W Lagakos, M. Hirsch, T. Merigan, 1990 .

Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group.

W. El-Sadr, H. Balfour, R. Murphy, 1998, The New England journal of medicine.

A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study Team.

M A Fischl, J. Phair, M. Hirsch, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients.

H. Balfour, S. Chou, A. Erice, 1989, The New England journal of medicine.